# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001001233-25-000024
Filing Date
2025-11-06
Accepted
2025-11-06 08:07:16
Documents
69
Period of Report
2025-09-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | sgmo-20250930.htm iXBRL | 10-Q | 1110589
2 | EX-10.1 | sgmo-20250930xex101.htm | EX-10.1 | 27541
3 | EX-10.2 | sgmo-20250930xex102.htm | EX-10.2 | 41411
4 | EX-10.3 | sgmo-20250930xex103.htm | EX-10.3 | 41749
5 | EX-31.1 | sgmo-20250930xex311.htm | EX-31.1 | 9872
6 | EX-31.2 | sgmo-20250930xex312.htm | EX-31.2 | 9950
7 | EX-32.1 | sgmo-20250930xex321.htm | EX-32.1 | 7018
| Complete submission text file | 0001001233-25-000024.txt |  | 6356917

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
8 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | sgmo-20250930.xsd | EX-101.SCH | 45847
9 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT | sgmo-20250930_cal.xml | EX-101.CAL | 60580
10 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT | sgmo-20250930_def.xml | EX-101.DEF | 221639
11 | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | sgmo-20250930_lab.xml | EX-101.LAB | 556361
12 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | sgmo-20250930_pre.xml | EX-101.PRE | 409431
72 | EXTRACTED XBRL INSTANCE DOCUMENT | sgmo-20250930_htm.xml | XML | 809785

Mailing Address 501 CANAL BLVD. RICHMOND CA 94084
Business Address 501 CANAL BLVD. RICHMOND CA 94084 5109706000
SANGAMO THERAPEUTICS, INC (Filer) CIK: 0001001233 (see all company filings)

EIN.: 680359556 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-30171 | Film No.: 251456282
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)